摘要
目的通过对比手术结合术后加压疗法和单纯保守疗法治疗乳腺癌术后2期淋巴水肿的效果,观察显微镜下淋巴管静脉吻合术(MLVI)结合术后加压法治疗乳腺癌术后2期淋巴水肿的近期效果。方法选取乳腺癌术后2期淋巴水肿在我科治疗的患者46人,随机分为两组:观察组(n=23)行MLVI结合后加压疗法;对照组(n=23)行单纯保守治疗。通过记录分析患者治疗前及术后相关数据,比较两组患者近期疗效。结果观察组患者MLVI手术均成功,术后恢复均良好,切口处无淋巴瘘、感染、血肿等并发症,术后给予相应加压治疗。对照组所有保守治疗过程均顺利进行;采用t检验分析两组患者患肢近端和远端%REC值,差异有统计学意义(P﹤0.05)。结论 MLVI结合术后加压疗法治疗乳腺癌术后2期淋巴水肿的近期疗效满意,与单纯保守治疗相比具有更高的肢体消肿率,远期效果有待进一步观察。
Objective： To compare the efficacy of microsurgical lymphaticovenous implementation （MLVI） and com-pression therapy or single conservative therapy in the treatment of stage II upper limb lymphedema in breast cancer pa-tients, to validate the short-term effects of the combined therapy. Method Forty-six patients with stage II upper limb lymphedema treated with MLVI＋compression therapy were included and randomized as study group （n=23） with MLVI＋compression therapy, and control group （n=23） with single conservative therapy, respectively. The related data of patients before and after surgery were recorded and compared between the two groups. Result All patients in the study group had successful MLVI surgery, with good postoperative recovery, and no lymphatic fistula, infection, or hematoma at the site of incision were observed, and then compression therapy was applied. In the control group, the conservative therapy was performed as planed successfully for all patients; The t-test showed significant differences between the %REC of proximal and distal site in the two groups （P〈0.05）. Conclusion The MLVI surgery combined with compression therapy is superior in reducing edema as compared with conservative therapy in the treatment of stage II lymphedema after breast cancer surgery in short term, though long-term follow-up of this combined therapy is needed.
出处
《癌症进展》
2016年第8期799-801,共3页
Oncology Progress
关键词
乳腺癌
淋巴水肿
淋巴管静脉吻合
显微外科
BCRL
MLVI
breast cancer
lymphedema
lymphaticovenous implantation
BCRL
MLVI
